Method of treatment for sexual dysfunction
AssigneePfizer Inc.
InventorsCharles Price Taylor JR., Andrew John Thorpe, Pieter Hadewijn Van Der Graaf, Christopher Peter Wayman, David Juergen Wustrow
Life of this patent
Estimating the term…
Abstract
Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of premature ejaculation.
Claims12
Use of an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, for the manufacture of a medicament for the treatment of premature ejaculation.
A method of treating premature ejaculation comprising administering an alpha-2-delta ligand, or a pharmaceutically acceptable derivative thereof, to a patient in need of such treatment.
A pharmaceutical product containing an alpha-2-delta ligand and an additional therapeutic agent as a combined preparation for simultaneous, separate or sequential use in the treatment of premature ejaculation.
Dependencies are inferred from the claim text.